The European Medicines Agency (EMA) simplified the navigation of its regulatory section on human medicines in November 2016. This is intended to help users from pharmaceutical companies find information more efficiently.
The navigation menu contains three main sections corresponding to the key medicinal product lifecycle stages:
Each main section provides an overview on a landing page, with sub-topics in the sub-menu in alphabetical order.
Regulatory information on herbal products is in a separate section, as these products are regulated differently in Europe.
Some regulatory topics span the product lifecyle. Entry pages on these transversal topics are in this overview section, in the sub-menu in alphabetical order:
- Advanced therapies
- Orphan designation
- Paediatric medicines
- Public health threats
- Support for early access
- Supporting SMEs
Some of these entry pages direct users to relevent content in the product lifecycle sections.
Before and after
EMA has simplified the main human regulatory navigation menu from more than thirty main sections to five main sections:
This responds to detailed feedback from a diverse range of users from the pharmaceutical industry. Most reported that they prefer to look up regulatory information in this way.
How useful is this page?
Average rating:Based on 20 ratings
Add your rating:
- See all ratings
5 ratings1 ratings0 ratings3 ratings11 ratings